“Our commitment to quality and experience allow us a head start of 6 to 8 months in access to innovative clinical trials” Published on 25/10/2024 We received a visit from Dr. Jordi Rodón, head of the Early Stage Drug Development Unit at MD Anderson Houston. Rodón specialises in early drug development, biomarker discovery, personalised cancer medicine and neuro-oncology.